Initiation of injectable opioid agonist treatment in hospital: A case report

被引：8
|
作者：
McAdam, Matthew [1 ]
Brar, Rupinder [2 ,3 ]
Young, Samantha [2 ,4 ]
机构：
[1] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada
[2] British Columbia Ctr Subst Use, 400-1045 Howe St, Vancouver, BC V6Z 2A9, Canada
[3] Univ British Columbia, Dept Family Med, Vancouver, BC, Canada
[4] Univ British Columbia, Dept Med, Vancouver, BC, Canada
来源：
DRUG AND ALCOHOL REVIEW | 2020年 / 39卷 / 02期
关键词：
opioid-related disorders; opioid substitution therapy; intravenous injections; diacetylmorphine; opioid addiction; HEROIN-ASSISTED TREATMENT; MEDICAL ADVICE; DRUG-USERS; METAANALYSIS; METHADONE;
D O I：
10.1111/dar.13020
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
Uncontrolled opioid withdrawal and pain often drive inpatients with opioid use disorder to leave hospital against medical advice, resulting in suboptimal medical and addiction treatment. When oral opioid agonist treatments such as methadone and buprenorphine/naloxone fail for management of craving and withdrawal, injectable opioid agonist treatment may serve to retain patients in care and link them to addiction services. We describe the case of a 47-year-old man with a severe, active opioid use disorder and daily use of illicitly manufactured fentanyl, who was re-admitted to hospital for post-operative management after leaving against medical advice due to uncontrolled opioid withdrawal. Intravenous hydromorphone was used to retain him in care, allowing for completion of his antibiotics and enrolment in ongoing community injectable opioid agonist treatment.
引用
收藏
页码：138 / 141
页数：4
相关论文
共 50 条
  • [1] Breastfeeding on Injectable Opioid Agonist Therapy: A Case Report
    Patricelli, Charissa J.
    Gouin, Isabelle J.
    Gordon, Shanlea
    Carter, Nicole
    Albert, Arianne
    Paquette, Vanessa
    Stewart, Karly
    George, Shawn
    Urbanoski, Karen
    [J]. JOURNAL OF ADDICTION MEDICINE, 2023, 17 (02) : 222 - 226
  • [2] Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case Series
    Brar, Rupinder
    Fairbairn, Nadia
    Colizza, Kate
    Ryan, Andrea
    Nolan, Seonaid
    [J]. JOURNAL OF ADDICTION MEDICINE, 2021, 15 (02) : 163 - 166
  • [3] Exploring Patients' Perceptions on Injectable Opioid Agonist Treatment: Influences on Treatment Initiation and Implications for Practice
    Friedmann, Zoe
    Binder, Annette
    Kinkel, Hans-Tilmann
    Kuehner, Claudia
    Zsolnai, Andreas
    Mick, Inge
    [J]. EUROPEAN ADDICTION RESEARCH, 2024, 30 (01) : 32 - 42
  • [4] HIV Treatment Initiation and Retention Among Individuals Initiated on Injectable Opioid Agonist Therapy for Severe Opioid Use Disorder: A Case Series
    Giang, Valerie
    Brar, Rupinder
    Sutherland, Christy
    Nolan, Seonaid
    [J]. JOURNAL OF ADDICTION MEDICINE, 2020, 14 (05) : 437 - 440
  • [5] Integrating injectable opioid agonist treatment into a drug treatment court program: A case study
    Jun, Jessica H.
    Fairbairn, Nadia
    [J]. SUBSTANCE ABUSE, 2018, 39 (04) : 493 - 496
  • [6] Case report: perioperative pain management in a patient on injectable opioid agonist treatment undergoing total knee arthroplasty
    Vaid, Patrycja
    Wilson, Patty
    Abelseth, Gregory
    Monty Ghosh, S.
    Zaganelli, Cristina
    Klemann, Jacqueline
    [J]. CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2020, 67 (11): : 1682 - 1684
  • [7] Case report: perioperative pain management in a patient on injectable opioid agonist treatment undergoing total knee arthroplasty
    Patrycja Vaid
    Patty Wilson
    Gregory Abelseth
    S. Monty Ghosh
    Cristina Zaganelli
    Jacqueline Klemann
    [J]. Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2020, 67 : 1682 - 1684
  • [8] Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
    Palis, Heather
    MacDonald, Scott
    Jun, Jennifer
    Oviedo-Joekes, Eugenia
    [J]. HARM REDUCTION JOURNAL, 2021, 18 (01)
  • [9] Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
    Heather Palis
    Scott MacDonald
    Jennifer Jun
    Eugenia Oviedo-Joekes
    [J]. Harm Reduction Journal, 18
  • [10] Injectable opioid agonist treatment: An evolutionary concept analysis
    Haines, Marlene
    O'Byrne, Patrick
    [J]. RESEARCH IN NURSING & HEALTH, 2021, 44 (04) : 664 - 671
12345